PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 140 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 200 | 0.0% | 0.00% | – |
Q2 2023 | $0 | – | 200 | 0.0% | 0.00% | – |
Q1 2023 | $0 | – | 200 | 0.0% | 0.00% | – |
Q4 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | -87.5% | 200 | -75.0% | 0.00% | – |
Q4 2020 | $8,000 | 0.0% | 800 | 0.0% | 0.00% | – |
Q3 2020 | $8,000 | +33.3% | 800 | +33.3% | 0.00% | – |
Q2 2020 | $6,000 | -82.4% | 600 | -89.0% | 0.00% | -100.0% |
Q1 2020 | $34,000 | +209.1% | 5,450 | +109.6% | 0.00% | +100.0% |
Q4 2019 | $11,000 | +10.0% | 2,600 | +13.0% | 0.00% | 0.0% |
Q3 2019 | $10,000 | -94.5% | 2,300 | -80.7% | 0.00% | -94.1% |
Q2 2019 | $183,000 | -9.0% | 11,900 | -14.3% | 0.02% | -19.0% |
Q1 2019 | $201,000 | +27.2% | 13,880 | -36.0% | 0.02% | +50.0% |
Q4 2018 | $158,000 | -86.4% | 21,677 | -63.4% | 0.01% | -82.5% |
Q3 2018 | $1,158,000 | -6.7% | 59,151 | -4.2% | 0.08% | -19.2% |
Q2 2018 | $1,241,000 | +54.4% | 61,747 | +25.4% | 0.10% | +43.5% |
Q1 2018 | $804,000 | -70.2% | 49,237 | -56.1% | 0.07% | -37.8% |
Q4 2017 | $2,700,000 | +26.3% | 112,040 | -16.2% | 0.11% | +38.8% |
Q3 2017 | $2,138,000 | -62.1% | 133,676 | -59.1% | 0.08% | -61.5% |
Q2 2017 | $5,641,000 | +486.4% | 326,473 | +277.4% | 0.21% | +407.3% |
Q1 2017 | $962,000 | -29.6% | 86,506 | -11.0% | 0.04% | -16.3% |
Q4 2016 | $1,367,000 | +45.6% | 97,146 | -16.6% | 0.05% | +14.0% |
Q3 2016 | $939,000 | +153.8% | 116,534 | +155.2% | 0.04% | +126.3% |
Q2 2016 | $370,000 | -65.4% | 45,666 | -48.7% | 0.02% | -72.9% |
Q1 2016 | $1,068,000 | +1.1% | 88,993 | -16.1% | 0.07% | +20.7% |
Q4 2015 | $1,056,000 | – | 106,081 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
State of Wyoming | 20,732 | $59,000 | 0.04% |
Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |